183 related articles for article (PubMed ID: 26693071)
1. Tumor suppressor SPOP mediates the proteasomal degradation of progesterone receptors (PRs) in breast cancer cells.
Gao K; Jin X; Tang Y; Ma J; Peng J; Yu L; Zhang P; Wang C
Am J Cancer Res; 2015; 5(10):3210-20. PubMed ID: 26693071
[TBL] [Abstract][Full Text] [Related]
2. Endometrial cancer-associated mutants of SPOP are defective in regulating estrogen receptor-α protein turnover.
Zhang P; Gao K; Jin X; Ma J; Peng J; Wumaier R; Tang Y; Zhang Y; An J; Yan Q; Dong Y; Huang H; Yu L; Wang C
Cell Death Dis; 2015 Mar; 6(3):e1687. PubMed ID: 25766326
[TBL] [Abstract][Full Text] [Related]
3. Destruction of DDIT3/CHOP protein by wild-type SPOP but not prostate cancer-associated mutants.
Zhang P; Gao K; Tang Y; Jin X; An J; Yu H; Wang H; Zhang Y; Wang D; Huang H; Yu L; Wang C
Hum Mutat; 2014 Sep; 35(9):1142-51. PubMed ID: 24990631
[TBL] [Abstract][Full Text] [Related]
4. SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.
Ma J; Chang K; Peng J; Shi Q; Gan H; Gao K; Feng K; Xu F; Zhang H; Dai B; Zhu Y; Shi G; Shen Y; Zhu Y; Qin X; Li Y; Zhang P; Ye D; Wang C
J Exp Clin Cancer Res; 2018 Jul; 37(1):145. PubMed ID: 29996942
[TBL] [Abstract][Full Text] [Related]
5. BTB domain-containing speckle-type POZ protein (SPOP) serves as an adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase.
Kwon JE; La M; Oh KH; Oh YM; Kim GR; Seol JH; Baek SH; Chiba T; Tanaka K; Bang OS; Joe CO; Chung CH
J Biol Chem; 2006 May; 281(18):12664-72. PubMed ID: 16524876
[TBL] [Abstract][Full Text] [Related]
6. Dysregulation of INF2-mediated mitochondrial fission in SPOP-mutated prostate cancer.
Jin X; Wang J; Gao K; Zhang P; Yao L; Tang Y; Tang L; Ma J; Xiao J; Zhang E; Zhu J; Zhang B; Zhao SM; Li Y; Ren S; Huang H; Yu L; Wang C
PLoS Genet; 2017 Apr; 13(4):e1006748. PubMed ID: 28448495
[TBL] [Abstract][Full Text] [Related]
7. SPOP suppresses testicular germ cell tumors progression through ubiquitination and degradation of DPPA2.
Wang J; Zhuang H; Zhang H; Li Q; Cao X; Lin Z; Lin T; Chen X; Ni X; Yang J; Zhao Y; Shen L; Wang H; Zhu J; Ye M; Jin X
Biochem Biophys Res Commun; 2021 Jun; 557():55-61. PubMed ID: 33862460
[TBL] [Abstract][Full Text] [Related]
8. SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein.
Geng C; Kaochar S; Li M; Rajapakshe K; Fiskus W; Dong J; Foley C; Dong B; Zhang L; Kwon OJ; Shah SS; Bolaki M; Xin L; Ittmann M; O'Malley BW; Coarfa C; Mitsiades N
Oncogene; 2017 Aug; 36(33):4767-4777. PubMed ID: 28414305
[TBL] [Abstract][Full Text] [Related]
9. The ubiquitin ligase adaptor SPOP in cancer.
Cuneo MJ; Mittag T
FEBS J; 2019 Oct; 286(20):3946-3958. PubMed ID: 31495053
[TBL] [Abstract][Full Text] [Related]
10. SPOP targets oncogenic protein ZBTB3 for destruction to suppress endometrial cancer.
Jin X; Wang J; Li Q; Zhuang H; Yang J; Lin Z; Lin T; Lv Z; Shen L; Yan C; Zheng J; Zhu J; Gong Z; Wang C; Gao K
Am J Cancer Res; 2019; 9(12):2797-2812. PubMed ID: 31911863
[TBL] [Abstract][Full Text] [Related]
11. Novel insights into the SPOP E3 ubiquitin ligase: From the regulation of molecular mechanisms to tumorigenesis.
Li XM; Wu HL; Xia QD; Zhou P; Wang SG; Yu X; Hu J
Biomed Pharmacother; 2022 May; 149():112882. PubMed ID: 35364375
[TBL] [Abstract][Full Text] [Related]
12. Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments.
Bouchard JJ; Otero JH; Scott DC; Szulc E; Martin EW; Sabri N; Granata D; Marzahn MR; Lindorff-Larsen K; Salvatella X; Schulman BA; Mittag T
Mol Cell; 2018 Oct; 72(1):19-36.e8. PubMed ID: 30244836
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer metastasis suppressor 1 (BRMS1) is destabilized by the Cul3-SPOP E3 ubiquitin ligase complex.
Kim B; Nam HJ; Pyo KE; Jang MJ; Kim IS; Kim D; Boo K; Lee SH; Yoon JB; Baek SH; Kim JH
Biochem Biophys Res Commun; 2011 Dec; 415(4):720-6. PubMed ID: 22085717
[TBL] [Abstract][Full Text] [Related]
14. S119N Mutation of the E3 Ubiquitin Ligase SPOP Suppresses SLC7A1 Degradation to Regulate Hepatoblastoma Progression.
He W; Zhang J; Liu B; Liu X; Liu G; Xie L; He J; Wei M; Li K; Ma J; Dong R; Ma D; Dong K; Ye M
Mol Ther Oncolytics; 2020 Dec; 19():149-162. PubMed ID: 33209975
[TBL] [Abstract][Full Text] [Related]
15. G3BP1 modulates SPOP to promote prostate tumorigenesis.
Mukhopadhyay C; Zhou P
Mol Cell Oncol; 2022; 9(1):2030171. PubMed ID: 35252555
[TBL] [Abstract][Full Text] [Related]
16. SPOP and cancer: a systematic review.
Clark A; Burleson M
Am J Cancer Res; 2020; 10(3):704-726. PubMed ID: 32266086
[TBL] [Abstract][Full Text] [Related]
17. The diverse roles of SPOP in prostate cancer and kidney cancer.
Wang Z; Song Y; Ye M; Dai X; Zhu X; Wei W
Nat Rev Urol; 2020 Jun; 17(6):339-350. PubMed ID: 32355326
[TBL] [Abstract][Full Text] [Related]
18. Speckle-type POZ protein suppresses hepatocellular carcinoma cell migration and invasion via ubiquitin-dependent proteolysis of SUMO1/sentrin specific peptidase 7.
Ji P; Liang S; Li P; Xie C; Li J; Zhang K; Zheng X; Feng M; Li Q; Jiao H; Chi X; Zhao W; Zhang S; Wang X
Biochem Biophys Res Commun; 2018 Jul; 502(1):30-42. PubMed ID: 29777712
[TBL] [Abstract][Full Text] [Related]
19. SPOP and CUL3 Modulate the Sonic Hedgehog Signal Response Through Controlled Degradation of GLI Family Transcription Factors.
Umberger PA; Ogden SK
Front Cell Dev Biol; 2021; 9():710295. PubMed ID: 34395437
[TBL] [Abstract][Full Text] [Related]
20. The speckle-type POZ protein (SPOP) inhibits breast cancer malignancy by destabilizing TWIST1.
Wei C; Liu Y; Liu X; Cheng J; Fu J; Xiao X; Moses RE; Li X; Fu J
Cell Death Discov; 2022 Sep; 8(1):389. PubMed ID: 36115849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
